1. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome
    H. Ziada-Bouchaar et al, 2017, Familial Cancer CrossRef
  2. Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
    Angela Toss et al, 2015, Biomed Res Int CrossRef
  3. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
    John M Carethers, 2015, WJG CrossRef
  4. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
    Jingwei Li et al, 2015, Oncol Rep CrossRef
  5. Synchronous tumours of the female reproductive tract
    C. Blake Gilks et al, 2018, Pathology CrossRef
  6. null
    Cindy L. Vnencak-Jones et al, 2018 CrossRef
  7. Disparities in gynecologic cancer genetics evaluation
    Emily M. Hinchcliff et al, 2019, Gynecologic Oncology CrossRef
  8. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
    Elisa Schmoeckel et al, 2019, Virchows Arch CrossRef
  9. Hereditary ovarian cancers: state of the art
    Angela Toss et al, 2019, Minerva Med CrossRef
  10. Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome
    Kaitlin M. McGarragle et al, 2019, Hered Cancer Clin Pract CrossRef
  11. The gynecological surveillance of women with Lynch syndrome in Sweden
    Gerasimos Tzortzatos et al, 2015, Gynecologic Oncology CrossRef
  12. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes
    Quentin B. Nakonechny et al, 2016, Surgical Pathology Clinics CrossRef
  13. Imaging of Hereditary Tumors of the Female Genital System
    Sarah M. Rothan et al, 2017, Journal of Computer Assisted Tomography CrossRef
  14. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
    Lucy Aitken et al, 2017, Intern Med J CrossRef
  15. PMS2 gene mutation results in DNA mismatch repair system failure in a case of adult granulosa cell tumor
    Wen-Chung Wang et al, 2017, J Ovarian Res CrossRef
  16. Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment
    Karen Hoffmann et al, 2020, EMBO J CrossRef
  17. Mismatch Repair Deficiency in Ovarian Carcinoma
    Susanna Leskela et al, 2020, The American Journal of Surgical Pathology CrossRef
  18. Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy
    Roberta Pastorino et al, 2020, PLoS ONE CrossRef
  19. RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report
    Elisa Gelli et al, 2020, Front. Oncol. CrossRef
  20. ERCC3, a new ovarian cancer susceptibility gene?
    Agostina Stradella et al, 2020, European Journal of Cancer CrossRef
  21. Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
    Mark R. Openshaw et al, 2020, Front. Digit. Health CrossRef
  22. For Women, Lynch Syndrome Is About More than Colon Cancer
    Wendy M. Parker et al, 2019, Cancer Prev Res CrossRef
  23. null
    Saritha Vara et al, 2021 CrossRef
  24. Hereditary ovarian tumour syndromes: current update on genetics and imaging
    K.P. Shanbhogue et al, 2021, Clinical Radiology CrossRef
  25. null
    Febina Ravindran et al, 2021 CrossRef
  26. Fertility preservation in patients with BRCA mutations or Lynch syndrome
    Giacomo Corrado et al, 2021, Int J Gynecol Cancer CrossRef
  27. null
    Hideki Yamamoto et al, 2021 CrossRef
  28. Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists
    Malak Itani et al, 2021, Abdom Radiol CrossRef
  29. A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
    Shuangfeng Chen et al, 2021, Front. Oncol. CrossRef
  30. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile
    Maria Rasmussen et al, 2021, Gynecologic Oncology CrossRef
  31. Opportunistic Salpingectomy at Time of Nongynecologic Elective Procedures Could Reduce Ovarian Cancer–Related Costs and Mortality
    Brittany N. Hughes et al, 2021, Journal of Gynecologic Surgery CrossRef
  32. null
    Alia Ghoneum et al, 2021 CrossRef
  33. Radiologic screening and surveillance in hereditary cancers
    Jamie E. Clarke et al, 2022, European Journal of Radiology Open CrossRef
  34. Hereditary Gynecologic Cancer Syndromes – A Narrative Review
    Stoyan Kostov et al, 2022, OTT CrossRef
  35. Germline mutations in Chinese ovarian cancer with or without breast cancer
    Ava Kwong et al, 2022, Molec Gen & Gen Med CrossRef
  36. Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population
    Valentina Elisabetta Bounous et al, 2022, JCM CrossRef
  37. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
    Sidrah Shah et al, 2022, IJERPH CrossRef